Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Health

Mycoprotein Shows Promise in Lowering Cholesterol Levels, Study Finds

Thinking of making a dietary change to improve your cholesterol levels? Consider incorporating mycoprotein, a fungal-derived food source rich in fiber and protein, into your meals. Research has shown that mycoprotein can effectively lower serum cholesterol concentrations, offering potential benefits for cardiovascular health.

A new study published in Clinical Nutrition delved into the impact of a home-based dietary intervention featuring mycoprotein on cholesterol and other biomarkers of cardiovascular disease (CVD) in overweight adults. With CVD being a leading cause of mortality, lifestyle modifications, including dietary changes, play a crucial role in mitigating associated risk factors.

The study involved a four-week dietary intervention with mycoprotein-containing food products, which were delivered to participants’ homes. The aim was to assess the effects of mycoprotein consumption on glucose, circulating cholesterol, and c-peptide concentrations in individuals with high body mass index (BMI) and hypercholesterolemia.

Results from the study revealed that the mycoprotein intervention led to a significant reduction in total circulating cholesterol concentrations among overweight adults with high cholesterol levels. This suggests that incorporating mycoprotein into the diet could potentially contribute to improving cholesterol profiles, offering a promising avenue for managing cardiovascular health.

These findings underscore the potential of mycoprotein as a dietary strategy for addressing hypercholesterolemia and its associated cardiovascular risks. The study’s remote delivery of mycoprotein-containing food products during the COVID-19 pandemic lockdown in the UK also highlights the real-world feasibility of integrating mycoprotein into home-based settings.

With the growing emphasis on lifestyle-based approaches to managing cardiovascular health, the study’s insights provide valuable evidence supporting the use of mycoprotein as a practical and effective dietary intervention for individuals seeking to improve their cholesterol profiles and reduce cardiovascular risk factors.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *